tiprankstipranks
Trending News
More News >

3SBio’s Mandi Shines in 2024 Double 11 Sales

3SBio’s Mandi Shines in 2024 Double 11 Sales

3SBio (HK:1530) has released an update.

Confident Investing Starts Here:

3SBio’s subsidiary, Zhejiang Sunshine Mandi Pharmaceutical, achieved remarkable success during the 2024 ‘Double 11’ sales campaign. Its Mandi® brand topped multiple online platforms, including Tmall, JD Pharmacy, and TikTok Shop, in various OTC categories. This achievement highlights the brand’s strong market presence and potential growth in the pharmaceutical sector.

For further insights into HK:1530 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App